TERT-BUTYL ((3R,4R)-4-HYDROXYPIPERIDIN-3-YL)CARBAMATE, 95.0%, 1g

Oxion Inverso OX.2053-PLPH-ICSI con objetivos LWD Plan fase 10x/20x/40x, equipo ICSI y mesa cruzada XY

3-Chloro-5-nitrophenol, 95.0%, 25g

7-chloro-6-methyl-2H-1,4-benzoxazin-3(4H)-one, 95.0%, 1g

4-Methyl-3-(trifluoromethyl)benzoic acid, 98.0%, 50g

2,4-Dichloro-8-fluoroquinoline, 100mg

Ajmalicina, ROTICHROM® CHR, 250 mg, envase de vidrio

1-Mesitylmethanamine, 97.0%, 10g

3-fluoro-4'-nitrobenzophenone, 97.0%, 2g

2-(Trimethylsilylethynyl)pyridine, 95%, 25g

1-[4-(TRIFLUOROMETHOXY)PHENYL]ETHANAMINE, 95.0%, 250mg

(2R,4R)-tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate, 95.0%, 500mg

2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfinyl)phenyl]-, 97%, 50mg